WO2006016150A1 - Improved secure dispensing system - Google Patents
Improved secure dispensing system Download PDFInfo
- Publication number
- WO2006016150A1 WO2006016150A1 PCT/GB2005/003130 GB2005003130W WO2006016150A1 WO 2006016150 A1 WO2006016150 A1 WO 2006016150A1 GB 2005003130 W GB2005003130 W GB 2005003130W WO 2006016150 A1 WO2006016150 A1 WO 2006016150A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dispensing system
- container
- user
- secure dispensing
- secure
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D55/00—Accessories for container closures not otherwise provided for
- B65D55/02—Locking devices; Means for discouraging or indicating unauthorised opening or removal of closure
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07C—TIME OR ATTENDANCE REGISTERS; REGISTERING OR INDICATING THE WORKING OF MACHINES; GENERATING RANDOM NUMBERS; VOTING OR LOTTERY APPARATUS; ARRANGEMENTS, SYSTEMS OR APPARATUS FOR CHECKING NOT PROVIDED FOR ELSEWHERE
- G07C9/00—Individual registration on entry or exit
- G07C9/30—Individual registration on entry or exit not involving the use of a pass
- G07C9/32—Individual registration on entry or exit not involving the use of a pass in combination with an identity check
- G07C9/37—Individual registration on entry or exit not involving the use of a pass in combination with an identity check using biometric data, e.g. fingerprints, iris scans or voice recognition
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47J—KITCHEN EQUIPMENT; COFFEE MILLS; SPICE MILLS; APPARATUS FOR MAKING BEVERAGES
- A47J2202/00—Devices having temperature indicating means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D2203/00—Decoration means, markings, information elements, contents indicators
- B65D2203/10—Transponders
Definitions
- the present invention relates to a secure dispensing system, comprising a container with a locking mechanism, which prevents the dispensing of material from the container until the locking mechanism is released.
- the secure dispensing system also comprises a control device, which is arranged to enable the release of the locking mechanism thereby allowing material to be dispensed from the container.
- a key is also provided to enable access to restricted functions of the system.
- the system will onJ,y enable release of the locking mechanism when a user has been authenticated by one or more biometric means of identification. More preferably, but not exclusively, the secure dispensing system comprises
- the secure dispensing system is used to dispense a pharmaceutical product.
- the secure dispensing system is able to trace the movement of material along different parts of a supply chain.
- Drugs of abuse are often opioid drugs (a term which includes not only drugs related chemically to morphine but also non-related structures which act at the same receptors in the brain) . These include many of the controlled drugs listed in the 1971 Misuse of Drugs Act and other drugs, including fentanyl. Opioids are used primarily to alleviate pain, although some of the CNS mechanisms that reduce the perception of pain also produce euphoria, and as such opioid drugs may be taken' for non-medicinal purposes in order to obtain the euphoric effect on mood. This gives the potential for abuse. Dependence on opioid drugs arises from repeated administration of opioids and is characterised by an overwhelming need to continue taking the drug or one with similar properties.
- Opioid analgesics particularly diamorphine, are abused for their euphoric effects and dependence develops rapidly with regular use.
- Methadone is a synthetic opioid, which is used as an analgesic and cough suppressant and as an alternative to diamorphine for treating opioid addicts. It is well absorbed orally, and when given to patients who are addicted to other opioids produces less acute oscillations between the high and early withdrawal symptoms. Withdrawal may develop more slowly with methadone than diamorphine.
- Opioids themselves, such as methadone, are often used in the management of other opioid, particularly heroin, dependency.
- the usual method in the UK is to replace the diamorphine with methadone, which is given as a liquid oral preparation; this is then gradually withdrawn over a period of time.
- other opioids such as buprenorphine may be used in for example, sublingual tablets or nasal spray form.
- Methadone is useful for withdrawal therapy because it can be given orally and its long half-life allows once-daily administration.
- Liquid oral preparations are usually preferred, and in withdrawal programmes it is usual for patients to attend pharmacies, or other treatment centres where the prescribed dose is given under supervision.
- methadone is between 60 and 120 mg per day.
- Methadone is available to pharmacies and clinics in a variety of forms such as; 1 mg/ml solution (500ml bottle) , 10 mg/ml solution in a 150ml or a 500ml bottle, 325g bulk powder for preparation or ampoules at various concentrations.
- the Drug Tariff Formula (DTF) of methadone is a solution of methadone hydrochloride in an aqueous solution of hydrogenated glucose syrup (Maltitol) . It has a bitter taste, and this determines the volume and concentration that can be given at one time.
- formulations in treatment regimens need to be presented in convenient formats, preferably with facilities available for recording dates and/or times of usage so as to control dosages administered remotely, i.e. without requiring the supervision of healthcare professionals at the time of administration.
- the high cost of supervision means that resources to treat patients may be limited. In the absence of close professional supervision the controlled drug or drug of abuse could be diverted to the black market or an overdose of the drug could be taken by the patient.
- the present invention addresses the scenario where it is desirable to dispense pharmaceutical goods to a user via a secure dispensing system.
- the present invention describes a secure dispensing system and its component parts where a user is authenticated by a biometric means of identification.
- a preferred embodiment of the various aspects of the invention comprises the incorporation of a control device, which is able to provide control over dispensing of the material within the container.
- a control device which is able to provide control over dispensing of the material within the container.
- Suitable technology for this level of control includes those described in GB2368061 and GB2368098, further improvements of which are described in GB2384707.
- Such systems generally comprise a dispenser, a locking mechanism on the dispenser to prevent dispensing of the material, a user interface allowing the user to input data, and a control device being arranged to receive the input data and to enable release of the locking mechanism to allow dispensing of the material.
- the present invention obtains a further level of security over the dispensing systems described in the above applications as it reguires a user to authenticate themselves to the system by a biometric means of identification.
- a biometric means of identification overcomes the problems associated with simpler identification means such as Personal Identification Numbers (PIN) where a number can be easily diverted to an unauthorised user.
- PIN Personal Identification Numbers
- Another advantage that the present invention demonstrates is that once the pharmaceutical product is secured within the container it cannot be diverted for illicit sale or use. Another advantage is that a patient could not take more than their recommended daily dose.
- Another clear advantage of the use of a secure dispensing system for supplying a drug such as methadone is the reduction in costs that would occur as a result.
- the costs of supplying methadone to treat an opiate addict are negligible.
- the cost of supervised consumption amounts to more than £20 per week per patient and with an estimated 10,000 to 15,000 patients currently undergoing supervised consumption of methadone in the UK, this amounts to a considerable cost.
- a secure dispensing system comprising the following:
- a container arranged to securely contain a quantity of a material within it comprising: - an internal locking mechanism to prevent unauthorised dispensing of the material from the container; and a delivery port to enable dispensing of a quantity of the material from the container,
- the biometric means of identification of a user can be selected from any known biometric identification means. These include but are not limited to hand geometry, retina scan, iris scan, fingerprint, facial characteristics, DNA sequence characteristics or voiceprints.
- the biometric means of authentication is one or more of the users fingerprints.
- the secure dispensing system may comprise means to scan and record one or more of a users fingerprints.
- the system requests that the user swipes one or more of his fingerprints. If the fingerprint that has been swiped by the user matches the fingerprint that is stored by the system then the user is authenticated and can go on to access particular functions defined by the system. If the fingerprint does not match the fingerprint that is stored by the system then the user is not authenticated and is asked to retry. If the user fails to provide an authenticated fingerprint scan within a predetermined time period or number of attempts, the system may block the user until such a time that an authorised person unblocks the system.
- a user is authenticated to the system he is able to access particular functions defined by the system. These functions may include, but are not limited to, the user being given access to dispense a dose of medicament.
- a timer starts .. whereby, for example, a dose can only be dispensed during a given time span. This can be as short as several seconds or longer depending on the requirements of the system and the user.
- the container that contains the material that is to be dispensed is preferably manufactured from a material that is resistant to tamper.
- the container is constructed from a material that can resist attack from tools that are typically available from hardware stores.
- the tools which are of particular interest, but are not limited to, are electric power drills with hammer action, circular saws, Jig Saws, Grinders with stone or metal discs, vice with 1 ton compression pressure and a 21b club hammer dropped repeatedly on to the container.
- resistant to attack it is meant that the container is able to withstand interference from a tool or device for a period of time that is relevant to the type of tool. For example the use of a Jig Saw for over 30 minutes would render the Jig Saw blade blunt and useless and would also probably overheat the device.
- the container is preferably able to withstand tamper in this way.
- the container is also preferably bullet-proof.
- the material that the container is manufactured from is a composite material.
- the composite material may comprise, but is not limited to, the following materials; aluminium, epoxy resin and silicon carbide.
- Other types of fibres or materials can be used to produce a composite material for use in the manufacture of the container. These include but are not limited to glass, wood, metals, concrete, silicon carbide, ceramic and titanium.
- the material can be woven or layered to produce a matrix.
- the secure dispensing system further comprises a valve and pump assembly, which is preferably inaccessible to the system user.
- inaccessible to the user it is meant that the valve and pump assembly is concealed within the locked container or other inaccessible area of the system.
- valve and pump assembly is preferably disposable. By making the valve and pump assembly disposable it ensures that if the material that is to be dispensed is a poison or toxin or if the material that is to be replaced in the container is different from the material that is already in the container the valve and pump assembly will not contaminate the new material.
- valve and pump assembly is also arranged in the container to produce an indirect pathway to the delivery port.
- the valve and pump assembly is also arranged in the container to produce an indirect pathway to the delivery port. In this way the best possible security is maintained as a user is unable to remove the contents of the container by siphoning, suction or any other direct or indirect means.
- the container has a delivery port from which the material held within the container is delivered through.
- the delivery port has a valve to prevent material from being extracted from the system' s delivery port.
- the container is a sealed unit with an internal locking mechanism that can be opened by an authorised person to allow the contents of the container to be replaced. In this way the container can be cost- effective, because the container is durable a user may only ever need to be allocated with one container. An authorised person can carry out the replacement of the material inside the container.
- the container may also be equipped with a biometric authentication device. This is preferably a fingerprint scanner.
- the container can also be equipped with a tamper indicator, which would alert the user or another person if the device had been opened or accessed in an unauthorised manner.
- control device Another part of the secure dispensing system is the control device.
- the control device is detachable from the container. This enables the control device to be used on more than one container if necessary.
- the control device may comprise a means for storing and transmitting data. This enables the control device to collect information such as a users biometric identification, information regarding the material that is to be dispensed, a dispensing regime or information about how the system is being used. This information can either be stored and subsequently downloaded when required or it can be transmitted to an authorised location or person. More preferably the means for storing and transmitting data is by one or more radio frequency identification (RFID) tags.
- RFID radio frequency identification
- the control device preferably further comprises some or all of following features.
- a display screen which can be used to facilitate communication with a user or other means of communication.
- a means for allowing data input these could be simple buttons or more sophisticated means of communication such as a voice or sound recognition.
- the control device can also be equipped with a tamper indicator, which would alert the user or another person if the device had been opened or accessed in an unauthorised manner.
- the control device can preferably communicate information to the user, this can be achieved by one of the means discussed above, although not limited to these means.
- the control device may also be equipped with a biometric authentication device. This is preferably a fingerprint scanner.
- a key there is provided a key.
- the user of the key must firstly be authenticated in order to functionalise the key. Once authenticated to the key the user is permitted to access restricted functions relating to the system.
- the means of authentication of a user is a biometric means. More preferably the biometric means of authentication is one or more of the users fingerprints.
- the key may comprise means to scan and record one or more of a users fingerprint. In order to authenticate a user, the key requests that the user swipes one or more of their fingerprints. If the fingerprint that has been , swiped by the user matches the fingerprint that is stored by the key the user is then authenticated, this enables the user to access specific functions of the secure dispensing system. If the fingerprint does not match the fingerprint that is stored by the key then the user is not authenticated and is asked to retry. If a user makes more unsuccessful attempts to authenticate themselves they may be blocked from using the key.
- the key has means for storing and transmitting data. More preferably this means for storing and transmitting data is one or more radio frequency identification (RFID) tags.
- RFID radio frequency identification
- a secure dispensing system whereby the different parts of the system are able to communicate with each other.
- this means of communication is achieved by one or more radio frequency identification (RFID) tags or other similar means of storing, transmitting and/or retrieving data.
- RFID radio frequency identification
- a plurality of RFID tags which are able to communicate with one another in order to authenticate the various components of the system.
- an RFID tag associated with the material contained within the container communicates with an RFID tag reader associated with the container, which in turn communicates with an RFID tag reader associated with the control device, and wherein the dispensing of the material will only occur if the data that is communicated between the parts of the system is authorized by the system.
- an RFID tag which is associated with the contents of the container communicates with an RFID tag reader associated with the container this means that only material that is authorised to be dispensed from the container can be used. This method is of an advantage to ensure overall security of the system.
- an RFID tag associated with the label on the medicament bottle would be read by an RFID tag reader associated with the container and this RFID tag would in turn communicate this information to an RFID tag associated with the control device, thereby only allowing dispensing of the material if authenticated.
- the material that is dispensed from the secure dispensing system is a pharmaceutical product.
- the material to be dispensed is a controlled drug or a drug of abuse.
- the controlled drug or drug of abuse is a Class A drug as defined by The Misuse of Drugs Act 1971. More preferably the controlled drug or drug of abuse is an opioid. More preferably still the opioid is methadone or a pharmaceutically acceptable salt or derivative thereof. Even more preferably the opioid is methadone hydrochloride.
- the secure dispensing system is able to dispense a measured dose of material contained within it according to a pre-programmed regime. More preferably the measured dose of material can be delivered in increments. 1.
- a method of securely dispensing a material from a container comprising the steps of; • Authentication of a first user to a key by one or more biometric means of identification;
- the biometric means of authentication is a scan of one or more of the users fingerprints.
- the key is authenticated it allows the first user to open the container to enable the contents of container to be replaced or filled.
- the user preferably has access to programme the control device to enable dispensing of material according to a regime.
- the communication of data between the control device and the container is achieved by RFID tags.
- the material to be dispensed is a pharmaceutical product.
- Figure 1 details the management of material along parts of a supply chain
- FIG. 2 details the secure dispensing system of the invention.
- FIG. 1 details the management of material along parts of a supply chain.
- the flow chart demonstrates the current way in which products such as pharmaceuticals are moved along a supply chain and the amount of control that is held over the pharmaceutical product at each point.
- At the first stage where the pharmaceutical product is manufactured complete control over the product is retained. But as the pharmaceutical product is moved from this site to wholesale distributors, then to the pharmacies, hospitals and clinics and finally on to the patient, control over the product is lost completely.
- the callouts on the flow diagram detail the way in which the present invention aims to retain control over each step of the distribution chain.
- a means for storing, receiving and/or transmitting data such as, for example, a Radio Frequency Identification (RFID) tag in this way ensures that the whereabouts of the material is known at all times.
- RFID Radio Frequency Identification
- an RFID tag can be programmed at the point of a products manufacture to contain information such as the name of the product, type or class of product, manufacturing date, expiry date, batch number etc. and this RFID tag can be applied to the product itself or to a label associated with the product.
- the product is then packaged for shipping where another RFID tag which has been programmed to contain information such as the number of batches in the carton, supplier's details, shipment details etc. may be applied.
- an RFID tag reader may be used to record and log the details of the shipment.
- a communication can be sent to acknowledge that the goods have arrived in a timely fashion at their destination.
- an alert can be sent by the RFID tags associated with the goods to warn that the goods are not at their destination.
- the goods can be automatically logged into an electronic register, which can then automatically update if necessary once the pharmacy dispenses -the goods.
- FIG. 2 details the container from the secure dispensing system in both front and side elevation views.
- the container (10) is made from a composite material and a dose delivery port (20) .
- a dose may be delivered directly to a drinking vessel for ease of dispensation to a user.
- the container is produced in two parts, which are locked together by an internal locking mechanism, which is inaccessible to the user. This enables the contents of the container to be refilled or replaced by an authorised person when necessary.
- the control device (30) of the secure dispensing system is shaped in such a manner that it is able to fit into the top of the container (10) .
- Embedded contacts between the control device and the container allow direct communication of data between the two parts of the system.
- the control device is equipped with a communication screen (40), which is able to communicate user specific information to the user.
- Function keys (50) allow the user to input data or information into the device.
- a fingerprint scanner (60) is included as part of the control device as a means to measure a users identification.
- An indication button (70) enables the system to indicate to the user whether specific functions such as delivery of a dose of material from within the container is authorised.
- the indication button can be programmed to turn green once the user has been authenticated to the control device and the control device has authorised that a dose of the patients medicament may be taken.
- the indication button can also be programmed to turn red if, for example, the user fails to be authenticated.
- the key (80) is shown in situ attached to the control device.
- the key once inserted into the control device allows a user to be authenticated to the control device. Once authenticated the user is allowed access to certain restricted functions of the system.
- the key is removable from the control device.
- the secure dispensing system described in the present invention could be used to contain a controlled drug such as methadone.
- a patient that has been prescribed methadone by their doctor or healthcare provider would take the prescription to their pharmacy.
- the patient's doctor or healthcare provider directly to the pharmacy could send an electronic prescription. Transfer of the prescription in this manner would ensure a secure transfer of the prescription ensuring that the prescription was not diverted in transit to the pharmacy.
- the pharmacist would then fill the prescription and supply the drug to the patient.
- the pharmacist would firstly authenticate himself or herself to a key. This would involve the pharmacist swiping one or more of their fingerprints onto a fingerprint scanner and waiting for the key to confirm that their fingerprints are accepted and they are authenticated to access the restricted functions of the system.
- the pharmacist may also need to programme the control device to dispense the drug to the patient in a regime.
- the patient may be prescribed with a dose of 60ml per day.
- the pharmacist can programme the control device to dispense the 60ml dose in increments three times a day between certain hours. In this way the patient would be able to take a 20ml dose between 7:00 and 8:00. The patient could then access their second dose between 15:00 and 16:00 and their third dose between 23:00 and midnight.
- This method of dosing is advantageous as it means that the patient does not have long periods of time between doses.
- the pharmacist would authenticate the patient to the device. This would involve swiping the patient's fingerprints across a fingerprint scanner on the container. An RFID tag in the control device would then record the information for use when authenticating a patient before taking a dose is dispensed.
- the patient is then able to take the secure dispensing system home and is in consequence able to dispense a dose of medicament according to their pre-programmed schedule.
- Changes to the programme may be made if and when necessary by the patients doctor, pharmacist or healthcare provider.
- the changes can be made either remotely by sending information directly to the patients control device or manually by an authorised and authenticated person.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/660,030 US20080140250A1 (en) | 2004-08-10 | 2005-08-09 | Secure Dispensing System |
CA002576126A CA2576126A1 (en) | 2004-08-10 | 2005-08-09 | Improved secure dispensing system |
EP05771780A EP1776670A1 (en) | 2004-08-10 | 2005-08-09 | Improved secure dispensing system |
AU2005271060A AU2005271060A1 (en) | 2004-08-10 | 2005-08-09 | Improved secure dispensing system |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0417793.7 | 2004-08-10 | ||
GB0417793A GB2417116A (en) | 2004-08-10 | 2004-08-10 | Secure dispensing system |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006016150A1 true WO2006016150A1 (en) | 2006-02-16 |
Family
ID=33017247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2005/003130 WO2006016150A1 (en) | 2004-08-10 | 2005-08-09 | Improved secure dispensing system |
Country Status (6)
Country | Link |
---|---|
US (1) | US20080140250A1 (en) |
EP (1) | EP1776670A1 (en) |
AU (1) | AU2005271060A1 (en) |
CA (1) | CA2576126A1 (en) |
GB (1) | GB2417116A (en) |
WO (1) | WO2006016150A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022533708A (en) * | 2019-05-22 | 2022-07-25 | バークシャー バイオメディカル コーポレイション | Computer-Assisted Oral Prescription Drug Administration, Related Systems, and Methods for Safely Dispensing Medications |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2843117B1 (en) * | 2002-07-30 | 2004-10-15 | Flamel Tech Sa | POLYAMINOACIDS FUNCTIONALIZED BY AT LEAST ONE HYDROPHOBIC GROUP AND THEIR PARTICULARLY THERAPEUTIC APPLICATIONS |
US20090024412A1 (en) | 2007-06-29 | 2009-01-22 | Mark Medvitz | Systems and methods for processing requests for pharmaceuticals that require insurer preapproval |
US8355992B1 (en) * | 2008-05-16 | 2013-01-15 | Michael Haugh | System and method for verifying the age of a controlled substance purchaser |
CN102238891B (en) * | 2008-07-21 | 2016-12-21 | 雀巢产品技术援助有限公司 | The liquid food of monitoring ingredient characteristics or beverage machine |
US20100228141A1 (en) * | 2009-03-05 | 2010-09-09 | Theodosios Kountotsis | Tamper resistant receptacle where access is actuated by breath samples and method of manufacturing the same |
NZ601156A (en) * | 2010-01-19 | 2014-09-26 | Synaptic Wireless Llc | Electronic locking system with wireless update and cascade lock control |
PL2654864T3 (en) | 2010-12-22 | 2021-07-12 | Syqe Medical Ltd. | System for drug delivery |
JP6173050B2 (en) * | 2012-06-27 | 2017-08-02 | キヤノン株式会社 | Image forming apparatus, information processing system, control method, and computer program |
US20150164144A1 (en) * | 2013-04-27 | 2015-06-18 | Kimree Hi-Tech Inc. | Identification method based on an electronic cigarette and electronic cigarette |
US10694655B2 (en) | 2013-08-27 | 2020-06-30 | Amvac Chemical Corporation | Tagged container tracking |
US11864485B2 (en) | 2013-10-25 | 2024-01-09 | Amvac Chemical Corporation | Tagged container tracking |
US11229155B2 (en) | 2013-10-25 | 2022-01-25 | Amvac Chemical Corporation | Tagged container tracking |
PL3160565T3 (en) | 2014-06-30 | 2022-01-10 | Syqe Medical Ltd. | Devices and systems for pulmonary delivery of active agents |
ES2736130T3 (en) | 2014-06-30 | 2019-12-26 | Syqe Medical Ltd | Pharmacological dose cartridge for an inhaler device |
RU2690401C2 (en) | 2014-06-30 | 2019-06-03 | Сике Медикал Лтд. | Method and device for evaporation and inhalation of released substances |
US11298477B2 (en) | 2014-06-30 | 2022-04-12 | Syqe Medical Ltd. | Methods, devices and systems for pulmonary delivery of active agents |
WO2016001922A1 (en) | 2014-06-30 | 2016-01-07 | Syqe Medical Ltd. | Methods, devices and systems for pulmonary delivery of active agents |
US9993602B2 (en) | 2014-06-30 | 2018-06-12 | Syqe Medical Ltd. | Flow regulating inhaler device |
WO2016205609A1 (en) * | 2015-06-17 | 2016-12-22 | The Johns Hopkins University | Personalized, tamper-resistant pill dispenser device and method |
EP3851102A1 (en) | 2016-01-06 | 2021-07-21 | Syqe Medical Ltd. | Low dose therapeutic treatment |
US20170281467A1 (en) * | 2016-03-29 | 2017-10-05 | Brandon Solotoff | Compact Pill Bottle Cap Requiring Biometric Authentication for Removal |
US10127360B2 (en) * | 2016-04-11 | 2018-11-13 | Firstenergy Ventures Corp. | Material dispenser and notification system |
IL264908B2 (en) * | 2016-08-25 | 2023-09-01 | Validose Inc | System and method for controlled medical therapy |
US9731103B1 (en) | 2017-01-13 | 2017-08-15 | Berkshire Biomedical, LLC | Computerized oral prescription administration devices and associated systems and methods |
US20180225422A1 (en) * | 2017-02-03 | 2018-08-09 | Alexis Burt FELDMAN | Medication dispensing apparatus and method |
US10792226B2 (en) | 2017-06-07 | 2020-10-06 | Berkshire Biomedical, LLC | Refill and dosage management devices and associated systems and methods for use with computerized oral prescription administration devices |
US20190206174A1 (en) * | 2017-12-29 | 2019-07-04 | Idemia Identity & Security USA LLC | Automated dispensing machine with improved security |
US10441509B2 (en) | 2018-03-16 | 2019-10-15 | Berkshire Biomedical, LLC | Computerized oral prescription administration with refillable medication dispensing devices and associated systems and methods |
US10813843B2 (en) * | 2019-01-07 | 2020-10-27 | Lester Fowler | Personalized medication dispenser |
US11628987B2 (en) | 2020-08-06 | 2023-04-18 | Tracy Lynn Fry | Personalized drinking cup with fingerprint reader |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5971593A (en) * | 1994-12-16 | 1999-10-26 | Diebold, Incorporated | Dispensing system for medical items |
US6382416B1 (en) * | 2000-06-27 | 2002-05-07 | Kathy S. Gainey | Medicine safety storage system |
US20030174554A1 (en) * | 2000-08-17 | 2003-09-18 | Dunstone Edward Simone | Security container for medicines and system for filing prescriptions |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5190185A (en) * | 1990-05-18 | 1993-03-02 | Baxter International Inc. | Medication transport and dispensing magazine |
US6512840B1 (en) * | 1996-05-30 | 2003-01-28 | Sun Microsystems, Inc. | Digital encoding of personal signatures |
US5930804A (en) * | 1997-06-09 | 1999-07-27 | Philips Electronics North America Corporation | Web-based biometric authentication system and method |
US6038666A (en) * | 1997-12-22 | 2000-03-14 | Trw Inc. | Remote identity verification technique using a personal identification device |
FR2772958B1 (en) * | 1997-12-24 | 2000-05-26 | Sgs Thomson Microelectronics | SECURITY SYSTEM, ESPECIALLY FOR A MOTOR VEHICLE |
US6078265A (en) * | 1998-02-11 | 2000-06-20 | Nettel Technologies, Inc. | Fingerprint identification security system |
US6353889B1 (en) * | 1998-05-13 | 2002-03-05 | Mytec Technologies Inc. | Portable device and method for accessing data key actuated devices |
DE19823731A1 (en) * | 1998-05-27 | 1999-12-02 | Bayerische Motoren Werke Ag | Remote control device for vehicles |
CA2276017A1 (en) * | 1998-06-25 | 1999-12-25 | Mr. Payroll Corporation | Pinless cash advances |
JP2000276445A (en) * | 1999-03-23 | 2000-10-06 | Nec Corp | Authentication method and device using biometrics discrimination, authentication execution device, and recording medium recorded with authentication program |
AU5450900A (en) * | 1999-06-03 | 2000-12-28 | Automated Business Companies | Advanced wireless phone system |
WO2001020463A1 (en) * | 1999-09-17 | 2001-03-22 | Fingloq Ab | Security arrangement |
SE0001056L (en) * | 2000-03-24 | 2001-09-25 | Wolf Fernlund | Arrangement and procedure for verifying a person's identity |
WO2002012660A1 (en) * | 2000-08-03 | 2002-02-14 | Koo Hong Sik | Method, device, and system for door lock |
GB0108228D0 (en) * | 2001-04-02 | 2001-05-23 | Glaxo Group Ltd | Medicament dispenser |
GB2391681B (en) * | 2002-08-01 | 2005-09-21 | Ncr Int Inc | Self-service terminal |
AU2003900586A0 (en) * | 2003-02-11 | 2003-02-27 | Argus Solutions Pty Ltd | Delivery of metered doses |
US6834775B1 (en) * | 2003-04-25 | 2004-12-28 | Sheila Collins | Programmable medicine dispenser |
US6992562B2 (en) * | 2003-06-10 | 2006-01-31 | Visteon Global Technologies, Inc. | Biometric keyless entry system |
US7731308B1 (en) * | 2005-01-14 | 2010-06-08 | David Lester Riemer | Secure medication container for use by medical personnel |
-
2004
- 2004-08-10 GB GB0417793A patent/GB2417116A/en not_active Withdrawn
-
2005
- 2005-08-09 CA CA002576126A patent/CA2576126A1/en not_active Abandoned
- 2005-08-09 WO PCT/GB2005/003130 patent/WO2006016150A1/en active Application Filing
- 2005-08-09 US US11/660,030 patent/US20080140250A1/en not_active Abandoned
- 2005-08-09 EP EP05771780A patent/EP1776670A1/en not_active Withdrawn
- 2005-08-09 AU AU2005271060A patent/AU2005271060A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5971593A (en) * | 1994-12-16 | 1999-10-26 | Diebold, Incorporated | Dispensing system for medical items |
US6382416B1 (en) * | 2000-06-27 | 2002-05-07 | Kathy S. Gainey | Medicine safety storage system |
US20030174554A1 (en) * | 2000-08-17 | 2003-09-18 | Dunstone Edward Simone | Security container for medicines and system for filing prescriptions |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022533708A (en) * | 2019-05-22 | 2022-07-25 | バークシャー バイオメディカル コーポレイション | Computer-Assisted Oral Prescription Drug Administration, Related Systems, and Methods for Safely Dispensing Medications |
Also Published As
Publication number | Publication date |
---|---|
GB2417116A (en) | 2006-02-15 |
AU2005271060A1 (en) | 2006-02-16 |
GB0417793D0 (en) | 2004-09-15 |
EP1776670A1 (en) | 2007-04-25 |
CA2576126A1 (en) | 2006-02-16 |
US20080140250A1 (en) | 2008-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080140250A1 (en) | Secure Dispensing System | |
US20220122709A1 (en) | Systems, methods, and apparatuses for securely dispensing one or more prescribed substances to a securely identified intended user | |
US7537005B2 (en) | Dose dispensing system and apparatus | |
US9492355B2 (en) | Smart medicine container | |
US20080300719A1 (en) | Drug dispensing control system | |
US20070260491A1 (en) | System for delivery and monitoring of administration of controlled substances | |
US20070299687A1 (en) | Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed | |
US20080027579A1 (en) | Dosage limiting medication dispensing method and apparatus | |
WO2010054205A2 (en) | Smart medicine container | |
US20220207939A1 (en) | Locking medication containers and methods of use thereof | |
US20190365607A1 (en) | Biometric Pill Dispensary System | |
US20170156985A1 (en) | Personal electronic medication safe | |
US20220367022A1 (en) | Systems, devices and methods for detecting and tracking drug extraction | |
US20220245981A1 (en) | Locking medication containers and methods of use thereof | |
US20230343159A1 (en) | Portal for Using A Lockable Medication Container | |
US20230360455A1 (en) | Communication System for a Locking Medication Container | |
US20230360454A1 (en) | Locking Medication Container Apparatus | |
US20230351827A1 (en) | A System and Method for Multiple Lockable Medication Containers | |
US20230343158A1 (en) | Security System for a Locking Medication Container | |
US20180161241A9 (en) | Pill-Safe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2576126 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005771780 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005271060 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2005271060 Country of ref document: AU Date of ref document: 20050809 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005271060 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2005771780 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11660030 Country of ref document: US |